IRCT20190524043684N1招募中3 期
Evaluation of therapeutic effect of Tiotropium Bromide in early stages of chronic obstructive pulmonary disease in patients of subspecialty clinics of Isfahan university of medical science in 2018 - 2019
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 85 years（—）
- 性别
- All
入选标准
- •age between 40 - 80 years
- •History of COPD stage GOLD 1 , 2
- •FEV1 to FVC ratio less than 0.7 after bronchodilator use
排除标准
- •Not signing informed consent
研究者
相似试验
招募中
3 期
The effectiveness of Tiotropium bromide in patients with severe asthmaIRCT20181015041353N1Zahedan University of Medical Sciences60
已完成
不适用
Efficacy of Tiotropium bromide (Spiriva 2.5 microgram Respimat 60 puffs) for chronic asthmatic cough refractory to intensive therapiesasthmaJPRN-UMIN000021064agoya City University Dept of Respiratory Medicine, Allergy and Clinical Immunology58
已完成
不适用
Comparison of the effect of tiotropium monotherapy versus tiotropium and indacaterol combination therapy in patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease (COPD)JPRN-UMIN000009077Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School60
进行中（未招募）
不适用
Influence of tiotropium bromide (Spiriva ®) plus salbutamol versus salbutamol on the mucin secretion and sputum properties in subjects with a COPD exacerbation-TIBROMUC- - TIBROMUCAnticholinergic bronchodilators, such as ipratropium bromide, may be used in combination with beta adrenergic agonists as SAlbutamol to produce bronchodilation in excess of that achieved by either agent alone.Therefore we will treat both study arms with salbutamol. One group A will receive tiotropium bromide with salbutamol, while the other group B will receive salbutamol.MedDRA version: 8.1Level: LLTClassification code 10010952Term: COPDEUCTR2006-005819-10-DEPhilipps-University Marburg
已完成
不适用
Efficacy evaluation of Tiotropium Respimat with AeroChamber PlusCOPDJPRN-UMIN000013980Hamamatsu medical center20